Biotech Values

[Jonathan Robinson]

The easiest thing to do is to allow it be used but to throw it back on the company through CU program - "see, we listened to AC but also guaranteed trials would be finished given results to date."

The political answer is approvable with CU. It may be inconvenient to longs and to the bio sector as a whole, but I think I agree with Dew that that is what is coming. It is the perfect solution to a thorny political problem. If it does not get used in a CU, it is DNDN's fault for having poor finances.

Jon